Australia Medicated Skincare Market

Australia Medicated Skincare Market Overview:

The Australia medicated skincare market size reached USD 930.06 Million in 2024. Looking forward, the market is projected to reach USD 1,983.60 Million by 2033, exhibiting a growth rate (CAGR) of 8.78% during 2025-2033. The market is experiencing significant growth due to increasing awareness about skin health and rising prevalence of skin conditions, including acne, eczema, and psoriasis. Consumers are also opting for dermatologically tested products with proven effectiveness. With the growing focus on natural and scientifically backed ingredients, the market for specialized skincare solutions is booming, which is further contributing to the Australia medicated skincare market share.

Key Trends of Australia Medicated Skincare Market:

Increased Focus on Anti-aging

In Australia, there is a growing demand for anti-aging medicated skincare products as consumers become more concerned with maintaining youthful skin. As the population ages people are increasingly seeking solutions to deal with the visible signs of aging such as wrinkles, fine lines, and sagging skin. Medicated products often containing active ingredients like retinol, peptides, and hyaluronic acid are gaining popularity due to their proven efficacy in reducing skin aging effects. For instance, in May 2025, AHC, Korea’s leading anti-aging skincare brand launched an exclusive new range in Australia at Priceline. Featuring advanced products like lifting eye creams, brightening serums, and intense hydration treatments AHC aims to revolutionize home skincare with professional-grade formulations that target aging, hydration, and skin clarity for radiant results. These products are used for preventive measures and reversing existing signs of aging. The market is further fueled by consumer trust in dermatologically tested scientifically backed solutions that offer visible results. With a strong focus on anti-aging, many brands are developing specialized treatments targeting both the skin's surface and deeper layers, making anti-aging a key segment driving growth in the Australian medicated skincare market.

To get more information on this market, Request Sample

Growing Demand for Natural Ingredients

There is a significant movement toward products that contain natural, organic, and scientifically proven ingredients in Australia, especially among consumers whose skin is sensitive. With increasing knowledge about the prospective irritants present in synthetic components, individuals are turning toward skincare products that are soothing yet effective. Ingredients in nature such as aloe vera, chamomile, and tea tree oil are being used in medicated skincare products to treat conditions like acne, eczema, and rosacea without irritating the skin. For instance, in November 2024, LA MAXIME launched SkinGlow5, a travel-friendly anti-aging skincare set featuring Australian native botanicals. This five-step system includes TSA-approved products designed for on-the-go use, delivering visible results in just five days. Priced at $250, it showcases premium ingredients like Kakadu Plum in spill-proof packaging for easy travel. This trend is closely tied to the increasing preference for sustainable and ethical skincare, as consumers demand products that are not only skin-friendly but also environmentally responsible. The shift toward natural and organic ingredients is playing a crucial role in propeling the Australia medicated skincare market growth, with brands incorporating plant-based formulations and ensuring they meet high standards for effectiveness and safety. This demand is expected to continue driving innovation and market expansion.

Rising Demand for Dermatologist-Recommended Products

One of the most significant trends in the medicated skincare market in Australia is the increase in the demand for dermatologist-recommended products. Consumers are increasingly looking for clinically tested and scientifically proven solutions to address concerns such as acne, eczema, pigmentation, and sensitive skin. Increased awareness regarding skin health, supported by medical input and professional advice, has increased the confidence in prescription as well as over-the-counter medicated products. This trend is especially evident among urban dwellers looking for efficient and safe treatments, frequently backed up by research and clinical findings. Products recommended by dermatologists are also seen to be of higher quality, safety, and long-term benefit than cosmetic ones. As skincare routines become more advanced, the reliance on medically approved products continues to grow, significantly driving Australia medicated skincare market demand across both retail and pharmacy distribution channels.

Growth Drivers of Australia Medicated Skincare Market:

Rising Prevalence of Skin Conditions

The increase in skin conditions such as acne, eczema, rosacea, and pigmentation is significantly fueling the demand for medicated skincare in Australia. These issues impact individuals of all ages, creating a continuous need for targeted solutions that extend beyond mere cosmetic products. Medicated skincare items, typically formulated with active ingredients and supported by dermatological research, deliver effective treatment and long-lasting relief. As awareness regarding the necessity of early intervention grows, consumers are gradually transitioning from general beauty products to clinically validated alternatives. This demand is bolstered by the accessibility of these products through pharmacies, dermatology clinics, and online platforms. As skin conditions become more prevalent due to lifestyle, environmental, and genetic factors, the medicated skincare sector is well-positioned for robust and ongoing growth in Australia.

Growing Awareness regarding Skin Health

Awareness regarding skin health is significantly influencing the Australian medicated skincare market, as consumers are increasingly prioritizing long-term wellness over temporary cosmetic solutions. Individuals are becoming more educated about how environmental stressors, unhealthy lifestyles, and aging can affect skin health, thus driving the demand for clinically validated medicated products. Solutions that are either recommended by dermatologists or supported by scientific research are seen as more reliable for ensuring effective treatment and prevention of issues such as acne, sensitivity, or premature aging. According to Australia medicated skincare market analysis, this rising awareness is motivating consumers to incorporate the regular use of medicated products into their daily skincare routines. The trend reflects a movement from reactive measures to proactive care, enhancing demand across retail, pharmacy, and professional dermatology channels.

Shift Toward Preventive Care

Preventive care is emerging as a major growth factor in the Australian medicated skincare market, as consumers increasingly focus on mitigating potential skin problems before they escalate. The popularity of early treatment strategies utilizing medicated skincare products is rising, particularly among younger individuals who are concerned about acne, sun damage, and initial signs of aging. Preventive routines frequently involve dermatologist-recommended cleansers, sunscreens, and treatments containing active ingredients like retinoids or antioxidants. This proactive mindset aligns with the growing interest in holistic health and wellness, with skin health being considered a vital part of overall self-care. By focusing on prevention, consumers can maintain healthier skin while simultaneously reducing the long-term necessity for more intensive treatments. This shift toward preventive care is anticipated to drive consistent usage and reinforce confidence in medicated skincare products.

Australia Medicated Skincare Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on skin condition, ingredient types, application type, distribution channel, and product feature.

Skin Condition Insights:

• Acne
• Eczema
• Psoriasis
• Rosacea
• Hyperpigmentation

The report has provided a detailed breakup and analysis of the market based on the skin condition. This includes acne, eczema, psoriasis, rosacea, and hyperpigmentation.

Ingredient Type Insights:

• Anti-Inflammatories
• Antibacterials
• Antifungals
• Antioxidants
• Moisturizers

The report has provided a detailed breakup and analysis of the market based on the ingredient type. This includes anti-inflammatories, antibacterials, antifungals, antioxidants, and moisturizers.

Application Type Insights:

• Creams
• Lotions
• Ointments
• Gels
• Serums

The report has provided a detailed breakup and analysis of the market based on the application type. This includes creams, lotions, ointments, gels, and serums.

Distribution Channel Insights:

• Over-The-Counter
• Prescription
• Online Retail
• Pharmacy
• Dermatologist Clinic

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes over-the-counter, prescription, online retail, pharmacy, and dermatologist clinic.

Product Feature Insights:

• Hypoallergenic
• Non-Comedogenic
• Fragrance-Free
• Paraben-Free
• Cruelty-Free

A detailed breakup and analysis of the market based on the product feature have also been provided in the report. This includes hypoallergenic, non-comedogenic, fragrance-free, paraben-free, and cruelty-free.

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Medicated Skincare Market News:

• In March 2025, Hydrinity announced its partnership with Device Consulting to enter the Australian market, targeting distribution through medical professionals specializing in cosmetic solutions. The move responds to growing consumer demand for premium skincare, with expectations for significant market growth over the next 5 to 7 years, according to COO Brent Nixon.
• In February 2023, Australian skincare brand tbh Skincare announced a price reduction amid rising living costs. Co-founder Rachael Wilde expressed that customers are pleasantly surprised by the decision. This change coincides with a new partnership with Priceline, making tbh products available online and in stores, targeting the acne-prone market.

Australia Medicated Skincare Market Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia medicated skincare market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia medicated skincare market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia medicated skincare industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.